• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性糖基化障碍:临床医生需要了解什么?

Congenital Disorders of Glycosylation: What Clinicians Need to Know?

作者信息

Lipiński Patryk, Tylki-Szymańska Anna

机构信息

Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Warsaw, Poland.

出版信息

Front Pediatr. 2021 Sep 3;9:715151. doi: 10.3389/fped.2021.715151. eCollection 2021.

DOI:10.3389/fped.2021.715151
PMID:34540767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8446601/
Abstract

Congenital disorders of glycosylation (CDG) are a group of clinically heterogeneous disorders characterized by defects in the synthesis of glycans and their attachment to proteins and lipids. This manuscript aims to provide a classification of the clinical presentation, diagnostic methods, and treatment of CDG based on the literature review and our own experience (referral center in Poland). A diagnostic algorithm for CDG was also proposed. Isoelectric focusing (IEF) of serum transferrin (Tf) is still the method of choice for diagnosing N-glycosylation disorders associated with sialic acid deficiency. Nowadays, high-performance liquid chromatography, capillary zone electrophoresis, and mass spectrometry techniques are used, although they are not routinely available. Since next-generation sequencing became more widely available, an improvement in diagnostics has been observed, with more patients and novel CDG subtypes being reported. Early and accurate diagnosis of CDG is crucial for timely implementation of appropriate therapies and improving clinical outcomes. However, causative treatment is available only for few CDG types.

摘要

先天性糖基化障碍(CDG)是一组临床异质性疾病,其特征在于聚糖合成及其与蛋白质和脂质连接的缺陷。本手稿旨在基于文献综述和我们自己的经验(波兰的转诊中心),对CDG的临床表现、诊断方法和治疗进行分类。还提出了一种CDG的诊断算法。血清转铁蛋白(Tf)的等电聚焦(IEF)仍然是诊断与唾液酸缺乏相关的N-糖基化障碍的首选方法。如今,虽然高效液相色谱、毛细管区带电泳和质谱技术并非常规可用,但也已被使用。自从下一代测序更广泛可用以来,诊断有了改进,报告了更多患者和新的CDG亚型。CDG的早期准确诊断对于及时实施适当治疗和改善临床结果至关重要。然而,仅对少数类型的CDG有病因治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/8446601/e6b3004efa33/fped-09-715151-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/8446601/e6b3004efa33/fped-09-715151-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31a6/8446601/e6b3004efa33/fped-09-715151-g0001.jpg

相似文献

1
Congenital Disorders of Glycosylation: What Clinicians Need to Know?先天性糖基化障碍:临床医生需要了解什么?
Front Pediatr. 2021 Sep 3;9:715151. doi: 10.3389/fped.2021.715151. eCollection 2021.
2
Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms.通过分析转铁蛋白糖型对I型先天性糖基化障碍进行实验室诊断。
Mol Diagn Ther. 2007;11(5):303-11. doi: 10.1007/BF03256251.
3
Improvement of CDG diagnosis by combined examination of several glycoproteins.通过多种糖蛋白联合检测改善先天性糖基化障碍(CDG)的诊断
J Inherit Metab Dis. 2004;27(5):581-90. doi: 10.1023/b:boli.0000042982.82131.a4.
4
High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation.用于先天性糖基化障碍诊断和亚型鉴定的完整转铁蛋白的高分辨率质谱糖谱分析
Transl Res. 2015 Dec;166(6):639-649.e1. doi: 10.1016/j.trsl.2015.07.005. Epub 2015 Aug 8.
5
Fast screening of N-glycosylation disorders by sialotransferrin profiling with capillary zone electrophoresis.通过毛细管区带电泳进行唾液酸转铁蛋白分析快速筛查N-糖基化障碍
Ann Clin Biochem. 2018 Nov;55(6):693-701. doi: 10.1177/0004563218779609. Epub 2018 Jun 11.
6
Screening using serum percentage of carbohydrate-deficient transferrin for congenital disorders of glycosylation in children with suspected metabolic disease.利用血清去糖基化转铁蛋白百分比对疑似代谢疾病儿童的先天性糖基化障碍进行筛查。
Clin Chem. 2008 Jan;54(1):93-100. doi: 10.1373/clinchem.2007.093450. Epub 2007 Nov 16.
7
Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation: long-term follow-up.先天性糖基化障碍的临床、生化和分子表型:长期随访。
Orphanet J Rare Dis. 2021 Jan 6;16(1):17. doi: 10.1186/s13023-020-01657-5.
8
Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin.通过血清转铁蛋白的毛细管区带电泳诊断先天性糖基化障碍
Clin Chem. 2004 Jan;50(1):101-11. doi: 10.1373/clinchem.2003.021568. Epub 2003 Nov 18.
9
Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation.用于研究糖肌营养不良症和先天性糖基化障碍的全球血清糖型分析
Mol Genet Metab Rep. 2016 Apr 17;7:55-62. doi: 10.1016/j.ymgmr.2016.03.002. eCollection 2016 Jun.
10
Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.I型和II型糖基化先天性疾病的表型和基因型谱。
Mol Genet Metab. 2017 Mar;120(3):235-242. doi: 10.1016/j.ymgme.2016.12.014. Epub 2017 Jan 3.

引用本文的文献

1
Congenital Disorder of Glycosylation Following ATP6AP1 Deficiency With Normal Liver Function: A Case Report.ATP6AP1缺乏伴肝功能正常的先天性糖基化障碍:一例报告
Clin Case Rep. 2025 Sep 7;13(9):e70847. doi: 10.1002/ccr3.70847. eCollection 2025 Sep.
2
Uncommon Factors Leading to Nephrotic Syndrome.导致肾病综合征的罕见因素。
Biomedicines. 2025 Aug 5;13(8):1907. doi: 10.3390/biomedicines13081907.
3
A comprehensive update of genotype-phenotype correlations in PMM2-CDG: insights from molecular and structural analyses.

本文引用的文献

1
The First Metabolome Analysis in Children with Epilepsy and ALG13-CDG Resulting from c.320A>G Variant.对携带c.320A>G变异导致的癫痫和ALG13-CDG患儿的首次代谢组学分析。
Children (Basel). 2021 Mar 23;8(3):251. doi: 10.3390/children8030251.
2
Transferrin isoform analysis from dried blood spots and serum samples by gel isoelectric focusing for screening congenital disorders of glycosylation.应用胶等电聚焦法从干血斑和血清样本中分析转铁蛋白同工型,用于筛查糖基化先天性疾病。
Acta Biochim Pol. 2021 Mar 5;68(1):139-142. doi: 10.18388/abp.2020_5576.
3
Congenital disorders of glycosylation: Prevalence, incidence and mutational spectrum in the Polish population.
磷酸甘露糖变位酶2缺陷型先天性糖基化异常(PMM2-CDG)中基因型-表型相关性的全面更新:来自分子和结构分析的见解
Orphanet J Rare Dis. 2025 Apr 30;20(1):207. doi: 10.1186/s13023-025-03669-5.
4
The long way to diagnosis: attention disorder, alcohol addiction or congenital disorder of glycosylation? A case report.诊断的漫漫长路:注意缺陷障碍、酒精成瘾还是先天性糖基化障碍?一例报告
BMC Psychiatry. 2025 Apr 29;25(1):435. doi: 10.1186/s12888-025-06862-9.
5
Diagnostic and Therapeutic Approaches in Congenital Disorders of Glycosylation.先天性糖基化障碍的诊断与治疗方法
Handb Exp Pharmacol. 2025;288:211-241. doi: 10.1007/164_2025_745.
6
Metabolic Liver Diseases Presenting as Pediatric Onset Hypoglycemia: A Hepatologist's Primer.以儿童期低血糖为表现的代谢性肝病:肝病专家指南
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102425. doi: 10.1016/j.jceh.2024.102425. Epub 2024 Oct 11.
7
A Deficiency in Glutamine-Fructose-6-Phosphate Transaminase 1 (Gfpt1) in Skeletal Muscle Results in Reduced Glycosylation of the Delta Subunit of the Nicotinic Acetylcholine Receptor (AChRδ).谷氨酰胺-果糖-6-磷酸转氨酶 1(Gfpt1)在骨骼肌中的缺乏导致烟碱型乙酰胆碱受体(AChRδ)的 Delta 亚单位糖基化减少。
Biomolecules. 2024 Oct 3;14(10):1252. doi: 10.3390/biom14101252.
8
Normal transferrin glycosylation does not rule out severe ALG1 deficiency.正常的转铁蛋白糖基化并不能排除严重的ALG1缺乏症。
JIMD Rep. 2024 Apr 16;65(3):135-143. doi: 10.1002/jmd2.12415. eCollection 2024 May.
9
FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms.FLT4 通过多种分子机制导致心血管和淋巴血管系统的发育障碍。
Cardiovasc Res. 2024 Sep 2;120(10):1164-1176. doi: 10.1093/cvr/cvae104.
10
Mixed-phase weak anion-exchange/reversed-phase LC-MS/MS for analysis of nucleotide sugars in human fibroblasts.混合相弱阴离子交换/反相 LC-MS/MS 分析人成纤维细胞中的核苷酸糖。
Anal Bioanal Chem. 2024 Jun;416(15):3595-3604. doi: 10.1007/s00216-024-05313-w. Epub 2024 Apr 27.
先天性糖基化障碍:波兰人群中的患病率、发病率及突变谱
Mol Genet Metab Rep. 2021 Feb 11;27:100726. doi: 10.1016/j.ymgmr.2021.100726. eCollection 2021 Jun.
4
Pediatric Liver Disease Patients and Secondary Glycosylation Abnormalities.小儿肝病患者与继发性糖基化异常
Front Pediatr. 2021 Jan 13;8:613224. doi: 10.3389/fped.2020.613224. eCollection 2020.
5
Congenital Disorders of Glycosylation from a Neurological Perspective.从神经学角度看先天性糖基化障碍
Brain Sci. 2021 Jan 11;11(1):88. doi: 10.3390/brainsci11010088.
6
Liver manifestations in a cohort of 39 patients with congenital disorders of glycosylation: pin-pointing the characteristics of liver injury and proposing recommendations for follow-up.39 例先天性糖基化障碍患者的肝脏表现:明确肝脏损伤的特征并提出随访建议。
Orphanet J Rare Dis. 2021 Jan 7;16(1):20. doi: 10.1186/s13023-020-01630-2.
7
Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation: long-term follow-up.先天性糖基化障碍的临床、生化和分子表型:长期随访。
Orphanet J Rare Dis. 2021 Jan 6;16(1):17. doi: 10.1186/s13023-020-01657-5.
8
Fatal outcome after heart surgery in PMM2-CDG due to a rare homozygous gene variant with double effects.由于一种具有双重效应的罕见纯合基因变异,PMM2-CDG患者心脏手术后出现致命结局。
Mol Genet Metab Rep. 2020 Nov 7;25:100673. doi: 10.1016/j.ymgmr.2020.100673. eCollection 2020 Dec.
9
Long term outcome of MPI-CDG patients on D-mannose therapy.MPI-CDG 患者接受 D-甘露糖治疗的长期疗效。
J Inherit Metab Dis. 2020 Nov;43(6):1360-1369. doi: 10.1002/jimd.12289. Epub 2020 Aug 9.
10
Dissecting Total Plasma and Protein-Specific Glycosylation Profiles in Congenital Disorders of Glycosylation.解析先天性糖基化障碍中的全血浆和蛋白质特异性糖基化图谱。
Int J Mol Sci. 2020 Oct 15;21(20):7635. doi: 10.3390/ijms21207635.